Download full report with analyst certification and important disclosures
Jun 29 2020, 07:40 IST/BST
Ratings and price correct at time of issue
|Company||Rating||Date||Previous Rating||Date||Closing Price|
We expect Symrise and Givaudan to emerge from the current crisis with enhanced propositions. We forecast healthy levels of organic revenue and EBITDA growth for FY20. We upgraded both stocks in March, and despite impressive recent share price performance and record valuations, we remain constructive on the fundamentals for both names and the broader Ingredients sector.